PharmaKB logo
Company Reports
Company Reports
Drug Reports
Drug Reports
Disease Reports
Disease Reports
Sets
Sets
Favorites
Favorites
Log in
Log in
AboutPricing
Company ReportsEntasis Therapeutics
Entasis Therapeutics(ETTX)
Download report
Favorite
Financial
Marketed Drugs
Clinical Trials
Financial
Stock price
*Currency in USD
Loading
Company Revenue
Quarterly
Quarterly
Annual
Annual
Projections
*Quarterly sales USD (in millions)
Plot placeholder
Mock data
Subscribe for the real data
Revenue by Drug
Loading
Marketed Drugs
Therapeutic Areas:
All
Classification:
All
Include Generics:
Trade Name
Drug Name
Approved
Patent Expires
Indication
XacduroSulbactam, Durlobactam2023-05-232033-2035
Respiratory tract infections
,
Urinary tract infections
,
Pneumococcal infections
,
Infectious pregnancy complications
,
Bacterial infections
,
Gonorrhea
,
Intraabdominal infections
,
Bacterial skin diseases
,
Escherichia coli infections
,
Soft tissue infections
,
Bacillary dysentery
,
Surgical wound infection
,
Staphylococcal infections
,
Bacterial endocarditis
,
Bacterial meningitis
,
Salmonella infections
,
Proteus infections
,
Acinetobacter infections
,
Listeriosis
,
Klebsiella infections
,
Meningococcal infections
,
Haemophilus infections
,
Human bites
,
Actinomycosis
Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Drug Name
Phase 1
Phase 2
Phase 3
Phase 4
Indication
Sulbactam
osteomyelitis
,
renal insufficiency
,
healthy volunteers/patients
,
escherichia coli infections
,
cleft palate
,
nontuberculous mycobacterium infections
,
community-acquired pneumonia
,
pyelonephritis
,
bacteremia
,
lung abscess
,
premature rupture fetal membranes
,
rupture
,
mortality
,
inflammation
,
iatrogenic disease
,
aspiration pneumonia
,
chorioamnionitis
,
premature birth
,
infections
,
communicable diseases
,
pneumonia
,
urinary tract infections
,
respiratory tract infections
,
sepsis
,
surgical wound infection
,
acinetobacter infections
,
bacterial pneumonia
,
bacterial infections
,
environmental biomarkers
,
wound infection
,
ventilator-associated pneumonia
,
intraabdominal infections
,
cholecystitis
,
cholelithiasis
,
blood coagulation disorders
,
hemostatic disorders
,
antibiotic prophylaxis
,
gonorrhea
,
bone fractures
,
open fractures
,
diabetes mellitus
,
diabetic foot
,
bacterial skin diseases
,
skin diseases
,
gallstones
,
acute cholecystitis
,
cholecystolithiasis
,
acalculous cholecystitis
,
gastrostomy
,
breast neoplasms
,
pulmonary infarction
,
soft tissue infections
,
gastroenteritis
,
heart block
,
multiple drug resistance
,
peritonitis
,
critical illness
,
asymptomatic infections
,
bacteriuria
,
healthcare-associated pneumonia
,
appendicitis
,
abdominal abscess
,
abscess
,
granuloma
,
pilonidal sinus
,
risk factors
,
aortic dissection
,
thoracic aortic aneurysm
,
heart valve diseases
,
aortic aneurysm
,
thoracic aorta dissection
,
acinetobacter baumannii
,
streptococcal infections
,
pregnancy outcome
Zoliflodacin
healthy volunteers/patients
Durlobactam
infections
,
renal insufficiency
,
healthy volunteers/patients
,
urinary tract infections
,
pyelonephritis
,
acinetobacter infections
,
ventilator-associated pneumonia
,
iatrogenic disease
,
bacteremia
Cephalosporin c
bacterial infections
Doxofylline
healthy volunteers/patients
Aspartame
lysosomal storage diseases
,
gangliosidoses
Bevifimod
amyotrophic lateral sclerosis
,
motor neuron disease
Cefpodoxime
enterobacteriaceae infections
,
healthy volunteers/patients
Corticorelin
retinal diseases
,
kidney diseases
,
chronic renal insufficiency
,
type 2 diabetes mellitus
,
diabetes mellitus
,
chronic kidney failure
,
anemia
,
renal insufficiency
,
hepatitis c
,
chronic hepatitis c
,
hepatitis
,
hepatitis a
Lactams
gram-negative bacterial infections
,
infections
,
communicable diseases
,
surgical wound infection
ETX2514SUL
renal insufficiency
,
infections
,
urinary tract infections
,
pyelonephritis
Trinessa
healthy volunteers/patients
Fluoroquinolone
chronic obstructive pulmonary disease
,
respiratory aspiration
,
healthy volunteers/patients
,
coronary artery disease
,
electrocardiography
,
overactive urinary bladder
,
endometriosis
,
cough
,
hot flashes
,
multiple endocrine neoplasia type 1
,
cystic fibrosis
,
tuberculosis
,
infections
,
communicable diseases
,
intraabdominal infections
,
sepsis
,
bronchiectasis
,
lung diseases
,
abdominal abscess
,
pelvic infection
,
pelvic inflammatory disease
,
diabetic foot
,
wound infection
,
ulcer
,
aspiration pneumonia
,
lung abscess
,
contraception
,
septic shock
,
respiratory tract infections
,
cholera
,
acute cholecystitis
,
healthcare-associated pneumonia
,
bacterial pneumonia
,
neurologic manifestations
,
joint diseases
,
acquired joint deformities
,
burns
,
hematologic diseases
,
febrile neutropenia
,
neutropenia
,
neoplasms
,
fever
,
pneumonia
,
chronic bronchitis
,
bronchitis
,
urinary tract infections
,
sinusitis
,
abscess
,
community-acquired pneumonia
,
bacterial infections
,
acute disease
,
pseudomonas infections
,
liver abscess
,
pyogenic liver abscess
,
maxillary sinusitis
,
rhinosinusitis
,
peritonitis
,
anthrax
,
disease progression
,
cholecystitis
,
cholangitis
,
wounds and injuries
,
chemical and drug induced liver injury
,
tonsillitis
,
bacterial skin diseases
,
bronchial diseases
,
pyelonephritis
,
cystitis
© 2020-2025 Collaborative Drug Discovery Inc. (CDD) | Terms of Use